Gainers
- Tempest Therapeutics (NASDAQ:TPST) stock moved upwards by 34.4% to $2.81 during Thursday's after-market session. The market value of their outstanding shares is at $29.0 million.
- Global Cord Blood (NYSE:CO) shares increased by 10.73% to $3.3. This security traded at a volume of 243.2K shares come close, making up 130.8% of its average volume over the last 100 days. The market value of their outstanding shares is at $401.1 million.
- Avalon Globocare (NASDAQ:AVCO) stock rose 8.86% to $0.5. The company's market cap stands at $44.4 million.
- Cortexyme (NASDAQ:CRTX) stock rose 7.48% to $2.73. The market value of their outstanding shares is at $98.6 million.
- Quoin Pharmaceuticals (NASDAQ:QNRX) stock moved upwards by 7.31% to $0.38. The market value of their outstanding shares is at $3.8 million.
- AcelRx Pharmaceuticals (NASDAQ:ACRX) stock increased by 7.03% to $0.2. The company's market cap stands at $30.0 million.
Losers
- Rhythm Pharmaceuticals (NASDAQ:RYTM) stock fell 11.5% to $3.45 during Thursday's after-market session. At the close, Rhythm Pharmaceuticals's trading volume reached 547.9K shares. This is 100.8% of its average volume over the last 100 days. The market value of their outstanding shares is at $173.8 million.
- Hillstream BioPharma (NASDAQ:HILS) stock declined by 6.75% to $0.85. The market value of their outstanding shares is at $9.8 million.
- Stealth BioTherapeutics (NASDAQ:MITO) stock decreased by 6.56% to $0.28. The company's market cap stands at $20.9 million.
- Acorda Therapeutics (NASDAQ:ACOR) shares decreased by 6.23% to $0.58. Acorda Therapeutics's trading volume hit 10.9 million shares by close, accounting for 2258.5% of its average volume over the last 100 days. The company's market cap stands at $14.0 million.
- Regulus Therapeutics (NASDAQ:RGLS) shares decreased by 6.02% to $0.23. The company's market cap stands at $33.2 million.
- Sema4 Holdings (NASDAQ:SMFR) stock fell 5.56% to $1.36. The company's market cap stands at $513.0 million. See Also: www.benzinga.com/money/best-healthcare-stocks/
This article was generated by Benzinga's automated content engine and reviewed by an editor.
